Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-28 Sale | 2023-02-27 9:15 pm | CinCor Pharma Inc. | CINC | HEALY JAMES Katabi Maha Sofinnova Management X L.P. Sofinnova Management X-A L.L.C. Sofinnova Venture Partners X L.P. Director 10% Owner | 6,000 | $14.32 | $85,920 | 0 (Indirect Direct) | View |
| 2022-06-10 Sale | 2023-02-27 5:10 pm | CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer | 6 | $15.21 | $91 | 0 (Indirect Direct) | View |
| 2022-08-15 Purchase | 2022-08-17 8:01 pm | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 10% Owner | 600,000 | $30 | $18,000,000 | 983,656 (Indirect) | View |
| 2022-08-15 Purchase | 2022-08-17 4:19 pm | CinCor Pharma Inc. | CINC | Sofinnova Partners SAS Sofinnova Capital IX 10% Owner | 133,333 | $30 | $3,999,990 | 4,220,979 (Indirect) | View |
| 2022-08-11 Purchase | 2022-08-15 3:46 pm | CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner | 500,000 | $30 | $15,000,000 | 6,073,949 (Indirect) | View |
| 2022-08-11 Purchase | 2022-08-15 3:45 pm | CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner | 506,000 | $30 | $15,180,000 | 35,411 (Indirect Direct) | View |
| 2022-08-11 Purchase | 2022-08-15 2:22 pm | CinCor Pharma Inc. | CINC | GENERAL ATLANTIC GENPAR (BERMUDA) L.P. GAP (Bermuda) L.P. GAP Coinvestments CDA L.P. General Atlantic (CIN) L.P. General Atlantic (SPV) GP LLC 10% Owner | 83,000 | $30 | $2,490,000 | 4,209,470 (Indirect) | View |
| 2022-08-11 Purchase | 2022-08-15 2:21 pm | CinCor Pharma Inc. | CINC | GENERAL ATLANTIC L.P. GENERAL ATLANTIC GENPAR L.P. General Atlantic Partners 100 L.P. GAP COINVESTMENTS III LLC GAP COINVESTMENTS IV LLC GAP Coinvestments V LLC General Atlantic Partners (Bermuda) EU L.P. General Atlantic Partners (Lux) SCSp General Atlantic (Lux) S.a r.l. General Atlantic GenPar (Lux) SCSp 10% Owner | 83,000 | $30 | $2,490,000 | 4,209,470 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 9:32 pm | CinCor Pharma Inc. | CINC | GENERAL ATLANTIC GENPAR (BERMUDA) L.P. GAP (Bermuda) L.P. GAP Coinvestments CDA L.P. General Atlantic (CIN) L.P. General Atlantic (SPV) GP LLC 10% Owner | 1,700,000 | $16 | $27,200,000 | 4,126,470 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 9:32 pm | CinCor Pharma Inc. | CINC | GENERAL ATLANTIC L.P. GENERAL ATLANTIC GENPAR L.P. General Atlantic Partners 100 L.P. GAP COINVESTMENTS III LLC GAP COINVESTMENTS IV LLC GAP Coinvestments V LLC General Atlantic Partners (Bermuda) EU L.P. General Atlantic Partners (Lux) SCSp General Atlantic (Lux) S.a r.l. General Atlantic GenPar (Lux) SCSp 10% Owner | 1,700,000 | $16 | $27,200,000 | 4,126,470 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 4:45 pm | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 470,000 | $16 | $7,520,000 | 496,323 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 4:38 pm | CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner | 325,000 | $16 | $5,200,000 | 5,573,949 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 4:36 pm | CinCor Pharma Inc. | CINC | Sofinnova Partners SAS Sofinnova Capital IX 10% Owner | 220,000 | $16 | $3,520,000 | 4,087,646 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 4:33 pm | CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner | 325,000 | $16 | $5,200,000 | 5,573,949 (Indirect) | View |
| 2022-01-11 Purchase | 2022-01-13 4:31 pm | CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer | 2,250 | $16 | $36,000 | 132,411 (Indirect Direct) | View |
| 2022-01-11 Purchase | 2022-01-13 4:28 pm | CinCor Pharma Inc. | CINC | Freeman Mason EVP Clinical Development | 2,600 | $16 | $41,600 | 2,600 (Indirect Direct) | View |
| 2022-01-11 Purchase | 2022-01-13 4:26 pm | CinCor Pharma Inc. | CINC | de Garidel Marc Chief Executive Officer | 12,500 | $16 | $200,000 | 12,500 (Direct) | View |
| 2022-01-11 Purchase | 2022-01-13 4:24 pm | CinCor Pharma Inc. | CINC | Coelho Mary Theresa EVP CFO & Chief BD Officer | 100 | $16 | $1,600 | 100 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-24 Equity Swap | 2023-02-28 4:29 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 5AM Opportunities I (GP) LLC 10% Owner | 4,937,646 | $0 | 0 (Indirect) | View |
| 2023-02-24 Equity Swap | 2023-02-27 9:15 pm | N/A N/A | CinCor Pharma Inc. | CINC | HEALY JAMES Katabi Maha Sofinnova Management X L.P. Sofinnova Management X-A L.L.C. Sofinnova Venture Partners X L.P. Director 10% Owner | 6,083,752 | $0 | 0 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-27 9:15 pm | N/A N/A | CinCor Pharma Inc. | CINC | HEALY JAMES Katabi Maha Sofinnova Management X L.P. Sofinnova Management X-A L.L.C. Sofinnova Venture Partners X L.P. Director 10% Owner | 19,608 | $0 | 0 (Direct) | View |
| 2023-02-24 Equity Swap | 2023-02-27 5:10 pm | N/A N/A | CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer | 2,594 | $0 | 0 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-27 5:10 pm | N/A 2029-09-24 | CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer | 335,854 | $0 | 0 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-24 6:40 pm | N/A 2031-12-09 | CinCor Pharma Inc. | CINC | Allison David D. Director | 33,353 | $0 | 0 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-24 6:40 pm | N/A 2031-06-17 | CinCor Pharma Inc. | CINC | Ignelzi Troy A. Director | 95,147 | $0 | 0 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-24 6:38 pm | N/A 2032-11-03 | CinCor Pharma Inc. | CINC | Kalb Michael Wayne EVP & Chief Financial Officer | 280,052 | $0 | 0 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-24 6:37 pm | N/A 2032-01-10 | CinCor Pharma Inc. | CINC | Lee June Director | 47,954 | $0 | 0 (Direct) | View |
| 2023-02-24 Equity Swap | 2023-02-24 6:36 pm | N/A N/A | CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer | 141,649 | $0 | 0 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-24 6:36 pm | N/A 2031-03-13 | CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer | 138,372 | $0 | 0 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-24 6:35 pm | N/A 2031-06-17 | CinCor Pharma Inc. | CINC | THERO JOHN F Director | 95,147 | $0 | 0 (Direct) | View |
| 2023-02-24 Equity Swap | 2023-02-24 6:34 pm | N/A N/A | CinCor Pharma Inc. | CINC | de Garidel Marc Chief Executive Officer | 12,500 | $0 | 0 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-24 6:34 pm | N/A 2031-06-17 | CinCor Pharma Inc. | CINC | de Garidel Marc Chief Executive Officer | 1,528,384 | $0 | 0 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 8:08 pm | N/A N/A | CinCor Pharma Inc. | CINC | de Garidel Marc Chief Executive Officer | 200,000 | $0 | 212,500 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 8:07 pm | N/A N/A | CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer | 15,000 | $0 | 156,649 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 8:04 pm | N/A N/A | CinCor Pharma Inc. | CINC | Kalb Michael Wayne EVP & Chief Financial Officer | 177,000 | $0 | 202,437 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 8:03 pm | N/A N/A | CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer | 40,000 | $0 | 42,600 (Direct) | View |
| 2023-01-11 Tax Withholding | 2023-01-19 4:34 pm | N/A N/A | CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer | 3,997 | $28.75 | 154,885 (Direct) | View |
| 2023-01-11 Exercise | 2023-01-19 4:34 pm | N/A N/A | CinCor Pharma Inc. | CINC | Pearce Catherine Chief Operating Officer | 13,235 | $0 | 154,885 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 4:18 pm | 2023-01-06 2033-01-05 | CinCor Pharma Inc. | CINC | Allison David D. Director | 1,499 | $8.34 | 1,499 (Direct) | View |
| 2022-11-04 Option Award | 2022-11-08 5:08 pm | N/A 2032-11-03 | CinCor Pharma Inc. | CINC | Kalb Michael Wayne EVP & Chief Financial Officer | 103,052 | $0 | 103,052 (Direct) | View |
| 2022-10-07 Option Award | 2022-10-12 4:28 pm | 2022-10-07 2032-10-06 | CinCor Pharma Inc. | CINC | Allison David D. Director | 524 | $23.85 | 524 (Direct) | View |
| 2022-08-05 Exercise | 2022-08-08 12:57 pm | N/A N/A | CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner | 29,411 | $13.6 | 5,603,360 (Direct) | View |
| 2022-08-05 Exercise | 2022-08-08 12:57 pm | N/A 2031-12-09 | CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner | 29,411 | $0 | 5,603,360 (Direct) | View |
| 2022-07-08 Option Award | 2022-07-20 4:44 pm | 2022-07-08 2032-07-07 | CinCor Pharma Inc. | CINC | Allison David D. Director | 881 | $14.19 | 881 (Direct) | View |
| 2022-04-08 Option Award(A) | 2022-07-20 4:39 pm | 2022-04-08 2032-04-07 | CinCor Pharma Inc. | CINC | Allison David D. Director | 1,038 | $12.04 | 1,038 (Direct) | View |
| 2022-04-08 Option Award | 2022-05-11 7:34 pm | N/A 2032-04-07 | CinCor Pharma Inc. | CINC | Allison David D. Director | 1,038 | $0 | 1,038 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-13 9:32 pm | N/A N/A | CinCor Pharma Inc. | CINC | GENERAL ATLANTIC GENPAR (BERMUDA) L.P. GAP (Bermuda) L.P. GAP Coinvestments CDA L.P. General Atlantic (CIN) L.P. General Atlantic (SPV) GP LLC 10% Owner | 10,676,470 | $0 | 4,126,470 (Indirect) | View |
| 2022-01-11 Conversion | 2022-01-13 9:32 pm | N/A N/A | CinCor Pharma Inc. | CINC | GENERAL ATLANTIC L.P. GENERAL ATLANTIC GENPAR L.P. General Atlantic Partners 100 L.P. GAP COINVESTMENTS III LLC GAP COINVESTMENTS IV LLC GAP Coinvestments V LLC General Atlantic Partners (Bermuda) EU L.P. General Atlantic Partners (Lux) SCSp General Atlantic (Lux) S.a r.l. General Atlantic GenPar (Lux) SCSp 10% Owner | 10,676,470 | $0 | 4,126,470 (Indirect) | View |
| 2022-01-11 Conversion | 2022-01-13 4:45 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner | 17,017,645 | $0 | 496,323 (Indirect) | View |
| 2022-01-11 Conversion | 2022-01-13 4:40 pm | N/A N/A | CinCor Pharma Inc. | CINC | CinRx Pharma LLC 10% Owner | 5,379,135 | $0 | 3,630,103 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-13 4:38 pm | N/A N/A | CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner | 23,095,377 | $0 | 5,573,949 (Indirect) | View |
| 2022-01-11 Conversion | 2022-01-13 4:36 pm | N/A N/A | CinCor Pharma Inc. | CINC | Sofinnova Partners SAS Sofinnova Capital IX 10% Owner | 17,017,645 | $0 | 4,087,646 (Indirect) | View |
| 2022-01-11 Conversion | 2022-01-13 4:33 pm | N/A N/A | CinCor Pharma Inc. | CINC | HEALY JAMES Director 10% Owner | 23,095,377 | $0 | 5,573,949 (Indirect) | View |